PUBLICATION

Tau accumulation is cleared by the induced expression of VCP via autophagy

Authors
Giong, H.K., Hyeon, S.J., Lee, J.G., Cho, H.J., Park, U., Stein, T.D., Lee, J., Yu, K., Ryu, H., Lee, J.S.
ID
ZDB-PUB-240925-2
Date
2024
Source
Acta Neuropathologica   148: 4646 (Journal)
Registered Authors
Cho, Hyun-Ju, Giong, Hoi-Khoanh, Lee, Jae-Geun, Lee, Jeong-Soo
Keywords
Autophagy, Tau clearance, Tau-overexpressing animal models, VCP/p97
MeSH Terms
  • Mice
  • Humans
  • Tauopathies/genetics
  • Tauopathies/metabolism
  • Tauopathies/pathology
  • Zebrafish*
  • tau Proteins*/genetics
  • tau Proteins*/metabolism
  • Animals, Genetically Modified*
  • Valosin Containing Protein*/genetics
  • Valosin Containing Protein*/metabolism
  • Brain/metabolism
  • Brain/pathology
  • Autophagy*/physiology
  • Alzheimer Disease/genetics
  • Alzheimer Disease/metabolism
  • Alzheimer Disease/pathology
  • Disease Models, Animal
  • Mice, Transgenic
  • Animals
(all 20)
PubMed
39316141 Full text @ Acta Neuropathol.
Abstract
Tauopathy, including frontotemporal lobar dementia and Alzheimer's disease, describes a class of neurodegenerative diseases characterized by the aberrant accumulation of Tau protein due to defects in proteostasis. Upon generating and characterizing a stable transgenic zebrafish that expresses the human TAUP301L mutant in a neuron-specific manner, we found that accumulating Tau protein was efficiently cleared via an enhanced autophagy activity despite constant Tau mRNA expression; apparent tauopathy-like phenotypes were revealed only when the autophagy was genetically or chemically inhibited. We performed RNA-seq analysis, genetic knockdown, and rescue experiments with clinically relevant point mutations of valosin-containing protein (VCP), and showed that induced expression of VCP, an essential cytosolic chaperone for the protein quality system, was a key factor for Tau degradation via its facilitation of the autophagy flux. This novel function of VCP in Tau clearance was further confirmed in a tauopathy mouse model where VCP overexpression significantly decreased the level of phosphorylated and oligomeric/aggregate Tau and rescued Tau-induced cognitive behavioral phenotypes, which were reversed when the autophagy was blocked. Importantly, VCP expression in the brains of human Alzheimer's disease patients was severely downregulated, consistent with its proposed role in Tau clearance. Taken together, these results suggest that enhancing the expression and activity of VCP in a spatiotemporal manner to facilitate the autophagy pathway is a potential therapeutic approach for treating tauopathy.
Genes / Markers
Figures
Figure Gallery (6 images)
Show all Figures
Expression
Phenotype
Mutations / Transgenics
Allele Construct Type Affected Genomic Region
ck205TgTransgenic Insertion
    krb4TgTransgenic Insertion
      krb5TgTransgenic Insertion
        1 - 3 of 3
        Show
        Human Disease / Model
        No data available
        Sequence Targeting Reagents
        Target Reagent Reagent Type
        atg5MO1-atg5MRPHLNO
        vcpMO4-vcpMRPHLNO
        1 - 2 of 2
        Show
        Fish
        Antibodies
        Orthology
        No data available
        Engineered Foreign Genes
        Marker Marker Type Name
        EGFPEFGEGFP
        mCherryEFGmCherry
        QFEFGQF
        1 - 3 of 3
        Show
        Mapping
        No data available